{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T10:54:09Z","timestamp":1769511249444,"version":"3.49.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1016\/j.ejphar.2008.10.030","type":"journal-article","created":{"date-parts":[[2008,10,22]],"date-time":"2008-10-22T08:47:59Z","timestamp":1224665279000},"page":"105-109","source":"Crossref","is-referenced-by-count":11,"title":["Suppression of dopamine-related side effects of morphine by aripiprazole, a dopamine system stabilizer"],"prefix":"10.1016","volume":"600","author":[{"given":"Minoru","family":"Narita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Takei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuru","family":"Shiokawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuri","family":"Tsurukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Matsushima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigemi","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megumi","family":"Asato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daigo","family":"Ikegami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiko","family":"Narita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taku","family":"Amano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiichi","family":"Niikura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoko","family":"Kuzumaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsutomu","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2008.10.030_bib1","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0885-3924(99)00085-8","article-title":"Opioid-induced emesis among hospitalized nonsurgical patients: effect on pain and quality of life","volume":"18","author":"Aparasu","year":"1999","journal-title":"J. Pain Symp. Manag."},{"key":"10.1016\/j.ejphar.2008.10.030_bib2","series-title":"Acute Extrapyramidal Syndromes","author":"Casey","year":"1995"},{"key":"10.1016\/j.ejphar.2008.10.030_bib3","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0022-3565(25)31039-6","article-title":"Naloxone antagonizes narcotic self blockade of emesis in the cat","volume":"203","author":"Costello","year":"1977","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2008.10.030_bib4","first-page":"448","article-title":"Differential involvement of D1 and D2 dopamine receptors in the expression of morphine withdrawal signs in rats","volume":"7","author":"Funada","year":"1996","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.10.030_bib5","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1002\/cncr.22665","article-title":"Opioid medications and longitudinal risk of delirium in hospitalized cancer patients","volume":"109","author":"Gaudreau","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.ejphar.2008.10.030_bib6","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0896-6273(00)80557-7","article-title":"Neuroscience of addiction","volume":"21","author":"Koob","year":"1998","journal-title":"Neuron"},{"key":"10.1016\/j.ejphar.2008.10.030_bib7","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejphar.2004.04.028","article-title":"Aripiprazole, a novel antipsychotic drug, preferentially increases dopamine release in the prefrontal cortex and hippocampus in rat brain","volume":"493","author":"Li","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.10.030_bib8","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S1526-5900(03)00556-X","article-title":"Management of opioid side effects in cancer-related and chronic noncancer pain: a systematic review","volume":"4","author":"McNicol","year":"2003","journal-title":"J. Pain"},{"key":"10.1016\/j.ejphar.2008.10.030_bib9","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.pnpbp.2004.06.020","article-title":"Aripiprazole: a new atypical antipsychotic with a different pharmacological mechanism","volume":"28","author":"Naber","year":"2004","journal-title":"Prog. Neuropsychopharmacol. Biol. Psych."},{"key":"10.1016\/j.ejphar.2008.10.030_bib10","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1254\/jjp.62.15","article-title":"Effects of kappa-agonist on the antinociception and locomotor enhancing action induced by morphine in mice","volume":"62","author":"Narita","year":"1993","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.10.030_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0163-7258(00)00099-1","article-title":"Regulations of opioid dependence by opioid receptor types","volume":"89","author":"Narita","year":"2001","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2008.10.030_bib12","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1177\/0269881105053308","article-title":"The place of partial agonism in psychiatry: recent developments","volume":"19","author":"Ohlsen","year":"2005","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2008.10.030_bib13","series-title":"The Mouse Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1997"},{"key":"10.1016\/j.ejphar.2008.10.030_bib14","first-page":"1019","article-title":"Management of common symptoms in terminally ill patients: Part II. Constipation, delirium and dyspnea","volume":"64","author":"Ross","year":"2001","journal-title":"Am. Fam. Phys."},{"key":"10.1016\/j.ejphar.2008.10.030_bib15","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1172\/JCI102363","article-title":"The role of the vestibular apparatus in the production of nausea and vomiting following the administration of morphine to man; clinical and experimental data including the effects of dramamine and benzedrine","volume":"29","author":"Rubin","year":"1950","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2008.10.030_bib16","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ejphar.2007.05.027","article-title":"Usefulness of the dopamine system-stabilizer aripiprazole for reducing morphine-induced emesis","volume":"570","author":"Shiokawa","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.10.030_bib17","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0033-3182(98)71301-5","article-title":"Olanzapine in the treatment of delirium","volume":"39","author":"Sipahimalani","year":"1998","journal-title":"Psychosomatics"},{"key":"10.1016\/j.ejphar.2008.10.030_bib18","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1365-2036.2004.01867.x","article-title":"Review article: clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics","volume":"19","author":"Tonini","year":"2004","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2008.10.030_bib19","first-page":"132","article-title":"Is there a final common neural pathway in delirium? Focus on acetylcholine and dopamine","volume":"5","author":"Trzepacz","year":"2000","journal-title":"Semin. Clin. Neuropsychiatry"},{"key":"10.1016\/j.ejphar.2008.10.030_bib20","series-title":"Cancer Pain Relief","author":"WHO","year":"1996"},{"key":"10.1016\/j.ejphar.2008.10.030_bib21","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1093\/ajhp\/60.23.2437","article-title":"Aripiprazole","volume":"60","author":"Winans","year":"2003","journal-title":"Am. J. Health-Syst. Pharm."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299908010637?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299908010637?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T05:14:45Z","timestamp":1738473285000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299908010637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":21,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S0014299908010637"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2008.10.030","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}